A double-blind clinical trial comparing the efficacy and safety of pure lanolin versus ammonium lactate 12% cream for the treatment of moderate to severe foot xerosis

Cutis. 2003 Jan;71(1):78-82.

Abstract

Xerotic skin is a pattern of reaction to a variety of disorders (eg, winter xerosis, hereditary ichthyosis) with abnormalities of desquamation in common. The trial described in this article was a double-blind randomized-comparison clinical trial investigating the effect of pure lanolin versus ammonium lactate 12% cream in treating moderate to severe foot xerosis. Xerosis was clinically assessed at baseline visit, and designated sites were reevaluated after 1, 2, and 4 weeks of therapy. Ninety-two patients were enrolled; 41 of these were excluded from analysis (25 were lost to follow-up, 8 were noncompliant, 1 was discharged from study because of an adverse event after visit 1, and 7 were noncompliant after visit 2). Although there was significant improvement in xerosis scores for both treatment groups after 2 and 4 weeks of treatment, no differences were statistically significant. Used twice daily for 4 weeks, pure lanolin and ammonium lactate cream were both effective in treating moderate to severe xerosis.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Adult
  • Aged
  • Double-Blind Method
  • Drug Combinations
  • Female
  • Follow-Up Studies
  • Foot Dermatoses / drug therapy*
  • Humans
  • Ichthyosis / drug therapy*
  • Lactic Acid / administration & dosage
  • Lactic Acid / therapeutic use*
  • Lanolin / administration & dosage
  • Lanolin / therapeutic use*
  • Male
  • Middle Aged
  • Quaternary Ammonium Compounds / administration & dosage
  • Quaternary Ammonium Compounds / therapeutic use*
  • Severity of Illness Index
  • Time Factors

Substances

  • Drug Combinations
  • Quaternary Ammonium Compounds
  • Lactic Acid
  • Lanolin